H3N2 flu death toll in Hong Kong has reached more than 118 people, marks the fatality rate to be 63%, mostly among elderly. Although medical experts in Hong Kong have claimed the epidemic is under control, different strains of flu viruses have risen around the northern hemisphere.
A different mutated strain Swine flu (H1N1) death toll hits 62 in Gujarat and 68 in Rajasthan, India. Even in the San Diego (US) region, more than 4,000 influenza cases have been confirmed and out growth the number of infection in the same period of 2014 by 2,600 people.
WHO initiated the production of flu vaccine since February, 2014 based on their prediction of flu infection. However, out of 1,314 patients who immunized with this vaccine, it was reported that only 30% is effective but far less than the expected 50%.
UK news media reports that the cold weather death toll this winder is expected to top 40,000, the HIGHEST number for 15 years. This number makes it the worse since 1999-2000’s landmark peak of 48,440 deaths.
Febico’s US, China, and TW patented Apogen® is extracted from its own in house spirulina strain and contains active essence ingredients includes Allophycocyanin, C-phycocyanin, spirulina growth factor, sulfated polysaccharide, peptide, nucleic acid, amino acids and trace elements. It works effectively against wide range of mutated flu viruses including the H1N1 and H3N2 in numerous in vivo studies.
Apogen® works against virus directly by inhibiting the replication of viruses and also provides a layer of protection around our healthy cells to prevent virus enters the cell. In vivo studies indicate via oral administration, survival rate can increase up to 80% compared to 0% of virus group.[pinterest][follow id=”FebicoHealth” ] [button color=”orange” size=”big” link=”http://store.febico.com/brands/Apogen.html” target=”blank” ]Click Here For the Febico Store![/button]